Positive hyaluronan/PEI/DNA complexes as a target-specific intracellular delivery to malignant breast canceral.

Drug Delivery

Volumn 16, Issue 7, 2009, Pages 357-362

  Sun, Xiyang ^a   Ma, Ping ^a   Cao, Xinke ^b   Ning, Li ^c   Tian, Yun ^a   Ren, Changshan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Institute of Biopharmaceuticals of Shandong Province   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Breast cancer

Indexed keywords

DNA; HERMES ANTIGEN; HYALURONIC ACID; IMINE; POLY(ETHYLENE IMINE); UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER SIZE; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; DNA; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; HYALURONIC ACID; IMINES; INTRACELLULAR FLUID; POLYETHYLENES;

EID: 70449091495     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540903059549     Document Type: Article

References (26)

1. Afify, A., Purnell, P., Nguyen, L. (2009). Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp Molec Pathol, 86, 95-100.
2. Boussif, O., Lesoualch, F., Zanta Antonietta, M., Mergny Djavaheri, M., Scherman, D., Demeneix, B., Behr, J.P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA, 92, 7297-7301
3. Breunig, M., Hozsa, C., Lungwitz, U, Wantanabe, K., Umeda, I., Kato, H., Goepferich, A. (2008). Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo. J Contr Rel, 130, 57-63.
4. Cai, S., Xie, Y., Bagby, T.R. (2008). Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J Surg Res, 147, 247-252
5. Choi, K.Y., Lee, S., Park, K., Kim, K., Park, J.H., Kwon, I.C., Jeong, S.Y. (2008). Preparation and characterization of hyaluronic acid-based hydrogel nanoparticles. J Phys Chem Solids, 69, 1591-1595
6. Chuthapisith, S., Eremin, J. (2009). Breast cancer chemoresistance: emerging importance of cancer stem cells. Surg Oncol. Available online at: www.sciencedirect.com, in press.
7. Godbey, W.T., Wu, K.K., Mikos, G.A. (1999). Poly(ethylenimine) and its role in gene delivery. J Contr Rel, 60, 149-160
8. Guechot, J., Edrief, S., Lasnier, E., Kuper, R. (2008). Automated assay of hyaluronic acid in serum. Immuno-analyse Biologie Specialisee, 23, 148-152
9. Huang, C.-S., Shen, C.-Y., Wang, H.-W. (2007). Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer. Clin Chim Acta, 384, 69-74.
10. Ito, T., Iida-Tanaka, N., Niidome, T., Kawano, T., Kubo, K., Yoshikawa, K., Sato, T., Yang, Z., Koyama, Y. (2006). Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: Protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J Contr Rel, 112, 382-388
11. Jaracz, S., Chen, J., Larisa, V. (2005). Recent advances in tumor- targeting anticancer drug conjugates. Bioorg Med Chem, 13, 5043-5054
12. Kafedjiiski, K., Jetti, R.K.R. (2007). Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery. Int J Pharm, 343, 48-58.
13. Kakimoto, S., Moriyama, T., Tanabe, T. (2007). Dual-ligand effect of transferrin and transforming growth factor alpha on polyethyleneimine- mediated gene delivery. J Contr Rel, 120, 242-249
14. Klonisch, T., Wiechec, E., Hombach-Klonisch, S. (2008). Cancer stem cell markers in common cancers-therapeutic implications. Trends Mol Med, 14, 450-460
15. Kumar, A., Sahoo, A.B., Montpeitit, A., Behera, S., Lockey, R.F., Mohapatra, S.S. (2007). Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides. Nanomed Nanotech Biol Med, 3, 132-137
16. Laurent, T.C. (1998). The chemistry, biology and medical applications of hyaluronan and its derivatives. London: Portland Press, 205-217
17. Lee, H., Mok, H., Lee, S., Oh, Y., Park, T.G., Gupta, K.C. (2007). Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Contr Rel, 119, 245-252
18. Liang, B., He, M.-L., Xiao, Z.-P., Li, Y., Chan, C.-Y., Kung, H.-F., Shuai, X.-T., Peng, Y. (2008). Synthesis and characterization of folate- PEG-grafted-hyperbranched-PEI for tumor- targeted gene delivery. Biochem Biophys Res Commun, 367, 874-880
19. Marhsall, E. (2000). Gene therapy death prompts review of adenovirus vector. Science, 286, 2244.
20. Pack, D.W., Hoffman, A.S., Pun, S., Stayton, P.S. (2005). Design and development of polymers for gene delivery. Nature Rev Drug Discov, 4, 581-593
21. Patnaik, S., Aggarwal, A., Nimesh, S., Goel, A., Ganguli, M., Saini, N., Singh, Y. (2006). PEI-alginate nanocomposites as efficient in vitro gene transfection agents. J Contr Rel, 114, 398-399
22. Segura, T., Chung, P.H., Lonnie, D. (2005). DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials, 26, 1575-1584
23. Toole, B.P., Slomiany, M.G. (2008). Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Sem Cancer Biol, 18, 244-250
24. Xu, R.-A., Wang, Q.-Z., Lv, Y.-H. (2007). Dose-response and control in viral vectors based preclinical and clinical therapy. Chin J Clin Pharmacol Ther, 12, 1193-1194
25. Yadav, A.K., Mishra, A.K., Mishra, P., Jain, S., Agarwal, G.P. (2007). Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomed Nanotech Biol Med, 3, 246-247
26. Yun, Y.H., Goetz, D.J., Yellen, P., Chen, W. (2004). Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials, 25, 147-157